Allantoin

1. INCI et CAS

INCI: Allantoin · CAS: 97-59-6

2. Rôle dans la formule

Allantoin is used around 0.1–0.5% in cosmetic leave-ons. This bulk listing does not by itself make an OTC skin-protectant claim.

3. Niveaux d'emploi typiques (repère de formulation)

• Creams, gels and washes: 0.1–0.5% in this reference.

Dissolve into warm water. It recrystallises if the level is too high for the solvent.

4. Sources réglementaires et conformité mondiale

• Use CosIng's information on Allantoin as a reference, then verify the specific grade and intended use under market rules.
• EU market placement under Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Allantoin is used before the cosmetic is placed on the EU market.
• Use the supplier TDS to confirm grade-specific details for Allantoin and review the destination market's requirements.

5. Sécurité et évaluation des risques

This level is a cosmetic-formulation guide; the listed level does not itself confer drug or OTC status while finished-product patch and stability testing remain necessary.

6. Stabilité et conditionnement

Hold the bulk material in a sealed, cool place shielded from light; for oxidation-sensitive formulas, consider an airless or pump pack; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• The formulation note describes Allantoin as part of a cosmetic direction focused on low-dose allantoin.

• This product entry does not support drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The available details for Allantoin should not be cited in support of whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI et CAS

INCI: Glycerin · CAS: 56-81-5

2. Rôle dans la formule

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Niveaux d'emploi typiques (repère de formulation)

• The gels and serums use-level reference is 3–8% in this reference.
• For creams, the reference gives 2–5%.
• Rinse-off: 2–4% in this reference.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Sources réglementaires et conformité mondiale

• Treat any CosIng entry for Glycerin as a reference only; verify the grade and intended use under current market rules.
• Regulation (EC) No 1223/2009 requires the final cosmetic with Glycerin to undergo a safety assessment at the level of the finished cosmetic product.
• Use the supplier TDS to confirm grade-specific details for Glycerin and review the destination market's requirements.

5. Sécurité et évaluation des risques

The stated concentration is a cosmetic-development reference; it should not be read as a drug authorization or OTC listing with patch and stability testing still needed for the completed formula.

6. Stabilité et conditionnement

Store the bulk in a closed container in a cool, shaded place; choose a package with oxidation sensitivity in view; use batch testing to verify stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic formulation concept for Glycerin centers on humectant function.

• The formulation note does not support drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The formulation record for Glycerin should not be used to substantiate a whitening effect, acne treatment, perspiration control, sun protection, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

Squalane provides the referenced hydrocarbon-emollient role in a plant-derived grade; mineral oil is not part of this guide.

3. Niveaux d'emploi typiques (repère de formulation)

• The formulation record indicates 2–6% for gel-creams in this reference.
• The guide range for dry oils is 10–30% in this reference.
• For balms, the reference gives 5–15%.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Sources réglementaires et conformité mondiale

• The CosIng record for Squalane, where listed, is informational rather than product-specific authorization.
• EU market placement under Regulation (EC) No 1223/2009 requires the completed product containing Squalane to receive its own safety assessment in the final product context.
• Confirm the received Squalane grade against supplier documentation, then verify the intended market's filing requirements.

5. Sécurité et évaluation des risques

This formulation note gives a cosmetic-use reference level; it should not be read as a drug authorization or OTC listing and the finished formula still needs patch and stability testing.

6. Stabilité et conditionnement

For bulk storage, avoid warmth and direct sun and keep the container closed; consider an airless or pump format when oxidation sensitivity warrants it; verify the chosen pack against the tested formula.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• This ingredient reference cannot substantiate therapeutic effects, curative outcomes, or unsupported certification statements.
• The formulation record for Squalane does not establish a whitening result, acne-treatment effect, antiperspirant use, sunscreen performance, or hair growth.